Documentos relacionados

1. Consensus on hemophilia in Mexico.
2. Acceptability of prenatal diagnosis and prenatal treatment of haemophilia using cell and gene therapies within US haemophilia community.
3. Reimbursing the value of gene therapy care in an era of uncertainty.
4. Health technology assessment for gene therapies in haemophilia.
5. Viral Vectors in Gene Replacement Therapy.
6. Development of a haemophilia A gene therapy shared decision-making tool for clinicians.
7. Decoding the complexity of on-target integration: characterizing DNA insertions at the CRISPR-Cas9 targeted locus using nanopore sequencing.
8. Outcomes and outcome measures.
9. Challenges in ageing persons with haemophilia.
10. Delivery of gene therapy in haemophilia treatment centres in the United States: Practical aspects of preparedness and implementation.